Efficacy and safety of 48 weeks of treatment with octreotide LAR in newly diagnosed acromegalic patients with macroadenomas: An open-label, multicenter, non-comparative study - Concepedia

Concepedia

Publication | Closed Access

Efficacy and safety of 48 weeks of treatment with octreotide LAR in newly diagnosed acromegalic patients with macroadenomas: An open-label, multicenter, non-comparative study

18

Citations

23

References

2005

Year

Silvia Grottoli, Roberta Celleno, Valentina Gasco, Rosario Pivonello, Davide Caramella, Alessandra Barreca, Federico Ragazzoni, Francesca Pigliaru, D. Alberti, Roberto Ferrara,

Journal of Endocrinological Investigation

Octreotide LarNon-comparative StudyAcromegalic Patients

References

	Year	Citations

Page 1